ECOG OPERATIONS OFFICE

经社理事会业务办公室的总体目标是提供 领导和支持多学科临床试验 旨在提高癌症治疗水平。要实现这一点，具体的 目标如下： A.通过缩短滞后时间提高临床试验效率 在协议制定、表格开发和协议审查方面； 开发(计算机)在线随机访问和核对表 以及取消不必要的注册要求，学习 要求和跟踪测量。 B.通过将我们的 现代癌症生物学的临床试验要素，包括 生物反应调节剂、生长因子、免疫化学、 癌基因和细胞遗传学的分子探针。 C.为我们的MOC和DOC主席提供资源以支持 制定方案，启动实验室的实施 项目，监督试验的进行，并规划新的 学习。 D.将患者的收入增加到主要方案中，如 NCI高度优先的倡议、第三阶段试验和生殖泌尿外科 通过提供行政和财政支持来征募癌症 来自新参与者或现有参与者的患者。

The overall goal of the ECOG Operations Office is to provide leadership and support for multi disciplinary clinical trials designed to improve cancer therapy. To achieve this the specific aims are as follows: A. Improving clinical trials efficiency by diminishing lag times in protocol development, forms development, and protocol review; developing (computer) on-line randomization access and checklists; and eliminating unnecessary requirements for registration, on study requirements and follow up measurements. B. Initiating new scientific thrusts by incorporating into our clinical trials elements of modern cancer biology, including biologic response modifier agents, growth factors, immunochemistry, molecular probes for oncogenes, and cytogenetics. C. Providing resources to our MOC and DOC chairs to support protocol development, to initiate implementation of laboratory projects, to monitor the conduct of trials, and to plan for new studies. D. Enhancing the accrual of patients into major protocols such as the NCI high priority initiatives, Phase 3 trials and Genitourinary cancers by providing administrative and fiscal support to enlist patients from new or established participants.